Casey's Announces Addition of Finance Leader Stanley J. Sutula III to its Board of Directors
Business Wire (Mon, 8-Jun 4:00 PM ET)
TipRanks (Mon, 8-Jun 11:00 AM ET)
Colgate-Palmolive Marks Historic 220th Anniversary as NYSE Highlights Innovation and Milestones
Market Chameleon (Mon, 8-Jun 5:27 AM ET)
NYSE Content Update: PointFive Raises $60 Million to Redefine Efficiency
PRNewswire (Mon, 8-Jun 8:55 AM ET)
Colgate-Palmolive Webcasts Fireside Chat at the dbAccess Global Consumer Conference
Business Wire (Wed, 20-May 9:30 AM ET)
Colgate Announces 1st Quarter 2026 Results
Business Wire (Fri, 1-May 6:55 AM ET)
Business Wire (Mon, 27-Apr 3:44 PM ET)
Colgate-Palmolive Webcasts 2026 First Quarter Earnings Conference Call May 1, 2026 - 8:30 a.m. ET
Business Wire (Fri, 17-Apr 9:30 AM ET)
Has CL been a good buy before earnings?
Market Chameleon (Wed, 15-Apr 6:13 AM ET)
Business Wire (Thu, 12-Mar 4:30 PM ET)
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns specialty pet food maker Hill's (almost one-fourth of sales), which sells the majority of its products through veterinarians and specialty pet retailers.
Colgate-Palmolive Company trades on the NYSE stock market under the symbol CL.
As of June 9, 2026, CL stock price climbed to $87.80 with 4,925,075 million shares trading.
CL has a beta of 0.39, meaning it tends to be less sensitive to market movements. CL has a correlation of 0.06 to the broad based SPY ETF.
CL has a market cap of $70.38 billion. This is considered a Large Cap stock.
Last quarter Colgate-Palmolive Company reported $5 billion in Revenue and $.97 earnings per share. This beat revenue expectation by $112 million and exceeded earnings estimates by $.02.
In the last 3 years, CL traded as high as $109.30 and as low as $67.62.
The top ETF exchange traded funds that CL belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
CL has underperformed the market in the last year with a price return of -0.4% while the SPY ETF gained +24.3%. CL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -5.6% and -3.1%, respectively, while the SPY returned +9.9% and -1.2%, respectively.
CL support price is $84.67 and resistance is $87.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CL shares will trade within this expected range on the day.
